NYSE:LLY • US5324571083
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELI LILLY & CO (LLY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-02 | B of A Securities | Maintains | Buy -> Buy |
| 2026-03-30 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-17 | HSBC | Downgrade | Hold -> Reduce |
| 2026-02-25 | RBC Capital | Initiate | Outperform |
| 2026-02-20 | Barclays | Initiate | Overweight |
| 2026-02-09 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-02-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-20 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-04 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-24 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-11-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-19 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-10 | Freedom Capital Markets | Downgrade | Buy -> Hold |
| 2025-11-10 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-31 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.124B 19.56% | 45.043B 32.00% | 65.179B 44.70% | 82.767B 26.98% | 95.865B 15.83% | 108.477B 13.16% | 119.633B 10.28% | 129.442B 8.20% | 137.952B 6.57% | 145.828B 5.71% | 152.653B 4.68% | |
| EBITDA YoY % growth | 11.853B 20.91% | 18.807B 58.67% | 31.693B 68.52% | 40.886B 29.01% | 48.974B 19.78% | 56.903B 16.19% | 64.729B 13.75% | 72.203B 11.55% | 78.153B 8.24% | 84.134B 7.65% | 87.759B 4.31% | |
| EBIT YoY % growth | 10.325B 24.70% | 17.04B 65.03% | 29.696B 74.27% | 38.842B 30.80% | 46.308B 19.22% | 53.884B 16.36% | 59.746B 10.88% | 66.131B 10.69% | 72.823B 10.12% | 78.557B 7.87% | 82.64B 5.20% | |
| Operating Margin | 30.26% | 37.83% | 45.56% | 46.93% | 48.31% | 49.67% | 49.94% | 51.09% | 52.79% | 53.87% | 54.14% | |
| EPS YoY % growth | 6.32 -21.88% | 13.00 105.70% | 24.21 86.23% | 34.96 44.39% | 42.70 22.16% | 50.23 17.62% | 55.74 10.99% | 61.53 10.38% | 66.92 8.76% | 71.88 7.41% | 76.08 5.84% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.32 119.29% | 8.17 29.54% | 9.24 31.61% | 10.24 35.80% | 9.19 25.49% | 10.03 22.70% | 10.33 11.84% | 4.64 -54.68% |
| Revenue Q2Q % growth | 17.709B 39.13% | 19.727B 26.80% | 21.529B 22.32% | 23.803B 23.38% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 8.647B 50.00% | 9.762B 22.61% | 11.037B 12.65% | 11.829B 7.70% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 8.028B 51.42% | 9.018B 28.45% | 10.202B 21.65% | 11.395B 26.81% | N/A | N/A | N/A | N/A |
All data in USD
39 analysts have analysed LLY and the average price target is 1225.45 USD. This implies a price increase of 30.98% is expected in the next year compared to the current price of 935.58.
ELI LILLY & CO (LLY) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of ELI LILLY & CO (LLY) is 7.32 USD and the consensus revenue estimate is 17.71B USD.
The consensus rating for ELI LILLY & CO (LLY) is 81.0256 / 100 . This indicates that analysts generally have a positive outlook on the stock.